Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
39.41
+0.42 (1.08%)
May 17, 2024, 4:00 PM EDT - Market closed
Revolution Medicines Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for RVMD stock have an average target of 42, with a low estimate of 30 and a high estimate of 48. The average target predicts an increase of 6.57% from the current stock price of 39.41.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RVMD stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 6 | 6 | 5 | 6 | 6 |
Buy | 3 | 4 | 5 | 6 | 5 | 6 |
Hold | 1 | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 11 | 12 | 11 | 11 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +11.65% | May 13, 2024 |
Wedbush | Wedbush | Buy Maintains $42 → $46 | Buy | Maintains | $42 → $46 | +16.72% | May 9, 2024 |
Needham | Needham | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +16.72% | May 9, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $43 → $45 | Buy | Maintains | $43 → $45 | +14.18% | Apr 12, 2024 |
Needham | Needham | Strong Buy Maintains $36 → $46 | Strong Buy | Maintains | $36 → $46 | +16.72% | Apr 12, 2024 |
Financial Forecast
Revenue This Year
6.76M
from 11.58M
Decreased by -41.59%
Revenue Next Year
5.66M
from 6.76M
Decreased by -16.40%
EPS This Year
-3.24
from -3.86
EPS Next Year
-3.54
from -3.24
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 38.0M | 46.2M | 73.8M | 564.7M | 1.0B |
Avg | 6.8M | 5.7M | 21.6M | 212.5M | 601.7M |
Low | n/a | n/a | n/a | n/a | 209.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 228.3% | 583.2% | 1,205.3% | 2,512.4% | 380.0% |
Avg | -41.6% | -16.4% | 282.2% | 883.1% | 183.1% |
Low | - | - | - | - | -1.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -3.14 | -2.99 | -1.41 | 0.61 | 3.24 |
Avg | -3.24 | -3.54 | -3.38 | -1.77 | -0.06 |
Low | -3.46 | -3.94 | -4.19 | -4.36 | -2.58 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.